SCHEMBL30823334

SCHEMBL30823334

COCCOCCOCCOCCOCCOCCOCCC(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 6/20 0.64
SIRT2 Q8IXJ6 2/20 0.55
SIRT1 Q96EB6 2/20 0.55
CPB1 P15086 1/20 0.54
CPB2 Q96IY4 1/20 0.54
MMP2 P08253 2/20 0.53
MMP9 P14780 2/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
MMP1 P03956 1/20 0.52
MMP3 P08254 1/20 0.52
MMP7 P09237 1/20 0.52
MMP13 P45452 1/20 0.52
LMNA P02545 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ITGB3 P05106 1/20 0.50
ITGAV P06756 1/20 0.50
SIRT3 Q9NTG7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30823356 0.94 CA1 (0.60) FOLH1SIRT2SIRT1CPB1CPB2
SCHEMBL27136756 0.92 FOLH1 (0.53) FOLH1SIRT2SIRT1CA1CA2
SCHEMBL24038544 0.88 FOLH1 (0.66) FOLH1SIRT2SIRT1CPB1CPB2
SCHEMBL24038542 0.88 FOLH1 (0.66) FOLH1SIRT2SIRT1CPB1CPB2
SCHEMBL29072085 0.86 FOLH1 (0.76) FOLH1SIRT2SIRT1CPB1CPB2
SCHEMBL29072081 0.86 FOLH1 (0.76) FOLH1SIRT2SIRT1CPB1CPB2
SCHEMBL25332996 0.86 SIRT2 (0.58) FOLH1SIRT2SIRT1CPB1CPB2
SCHEMBL25333001 0.86 SIRT2 (0.58) FOLH1SIRT2SIRT1CPB1CPB2
SCHEMBL23451317 0.86 SIRT2 (0.58) FOLH1SIRT2SIRT1CPB1CPB2
SCHEMBL23451316 0.86 SIRT2 (0.58) FOLH1SIRT2SIRT1CPB1CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577526-A1 VHH ANTIBODY CONJUGATES Abdera Therapeutics Inc. (US) 2025-07-02 EP disclosed
WO-2024044549-A1 VHH ANTIBODY CONJUGATES Abdera Therapeutics Inc. (US) 2024-02-29 WO disclosed